GlassScriptPhysician profile
Lemuel L Dent
NPI 1235139916
$10,900.16
in general payments reported to CMS, 2019-2025
22 companies · $3,217 in 2025
The $3,217 reported for 2025 was more than what 82% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,927 · 2020: $95.61 · 2021: $80.41 · 2022: $257 · 2023: $298 · 2024: $5,026 · 2025: $3,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $930 · Travel and Lodging: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $930.20 |
| Travel and Lodging | $609.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,956.92 | 2019-2025 | |
| Becton, Dickinson and Company | $164.87 | 2023-2024 | Phasix Mesh |
| Alexion Pharmaceuticals, INC. | $141.52 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $81.17 | 2023-2025 | Libtayo |
| Stryker Corporation | $60.91 | 2023 | Spy-Phi System |
| Organogenesis INC. | $52.80 | 2023 | Puraply |
| Access Pro Medical, LLC | $49.04 | 2023 | Matriderm |
| Csl Behring | $46.15 | 2020-2023 | Kcentra |
| Sanara Medtech INC. | $43.23 | 2024 | Biasurge, Celleraterx |
| Davol INC. | $39.11 | 2021 | |
| Merck Sharp & Dohme LLC | $33.23 | 2025 | Keytruda |
| W. L. Gore & Associates, INC. | $32.85 | 2019-2024 | Gore Synecor Biomaterial |
| Astrazeneca Pharmaceuticals LP | $32.33 | 2023-2024 | Andexxa |
| Endogastric Solutions, INC | $29.63 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.49 | 2025 | Exparel |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $19.63 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bard Peripheral Vascular, INC. | $19.25 | 2022 | |
| Smith+Nephew, INC. | $17.88 | 2025 | Collagenase Santyl |
| Kerecis Limited | $16.78 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Portola Pharmaceuticals, LLC | $14.24 | 2019 | |
| Conmed Corporation | $13.46 | 2023 | Airseal |
| Heron Therapeutics, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lemuel Dent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.